Gemcitabine combined with capecitabine compared to gemcitabine with or without erlotinib as first-line chemotherapy in patients with advanced pancreatic cancer: Comparative effectiveness study.

被引：0
|
作者：
Cho, Jangho
Lim, Jae Yun
Cho, Jae Yong
机构：
[1] Gangnam Severance Hosp, Dept Med Oncol, Seoul, South Korea
[2] Gangnam Severance Hosp, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15132
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effectiveness study of gemcitabine, oxaliplatin, and capecitabine as first-line treatment for nonresectable biliary tract cancer
    Jensen, Lars Henrik
    Mellergaard, Anne Haahr
    Hoegdall, Dan
    Larsen, Ole
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [22] First-line chemotherapy with gemcitabine in advanced pancreatic cancer: a retrospective single-center analysis
    Magalhaes, H.
    Cassiano Neves, M.
    Fontes e Sousa, M.
    Machado, M.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Luis, M.
    Sales, C.
    ANNALS OF ONCOLOGY, 2015, 26
  • [23] Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma
    Yoshiyuki Yamagishi
    Hajime Higuchi
    Motoko Izumiya
    Gen Sakai
    Hideko Iizuka
    Shoko Nakamura
    Masayuki Adachi
    Sigenari Hozawa
    Hiromasa Takaishi
    Toshifumi Hibi
    Journal of Gastroenterology, 2010, 45 : 1146 - 1154
  • [24] Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma
    Cho, JY
    Paik, YH
    Chang, YS
    Lee, SJ
    Lee, DK
    Song, SY
    Chung, JB
    Park, MS
    Yu, JS
    Yoon, DS
    CANCER, 2005, 104 (12) : 2753 - 2758
  • [25] Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma
    Yamagishi, Yoshiyuki
    Higuchi, Hajime
    Izumiya, Motoko
    Sakai, Gen
    Iizuka, Hideko
    Nakamura, Shoko
    Adachi, Masayuki
    Hozawa, Sigenari
    Takaishi, Hiromasa
    Hibi, Toshifumi
    JOURNAL OF GASTROENTEROLOGY, 2010, 45 (11) : 1146 - 1154
  • [26] Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer
    Petrioli, Roberto
    Roviello, Giandomenico
    Fiaschi, Anna I.
    Laera, Letizia
    Roviello, Franco
    Marrelli, Daniele
    Francini, Edoardo
    ANTI-CANCER DRUGS, 2015, 26 (06) : 682 - 686
  • [27] Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
    Chung, Kwang Hyun
    Ryu, Ji Kon
    Son, Jun Hyuk
    Lee, Jae Woo
    Jang, Dong Kee
    Lee, Sang Hyub
    Kim, Yong-Tae
    GUT AND LIVER, 2017, 11 (02) : 298 - 305
  • [28] Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
    Wilbur, H. Catherine
    Durham, Jennifer N.
    Lim, Su Jin
    Purtell, Katrina
    Bever, Katherine M.
    Laheru, Daniel A.
    De Jesus-Acosta, Ana
    Azad, Nilofer S.
    Wilt, Bradley
    Diaz, Luis A.
    Le, Dung T.
    Wang, Hao
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (08): : 1672 - 1677
  • [29] Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
    Javle, M.
    Yu, J.
    Garrett, C.
    Pande, A.
    Kuvshinoff, B.
    Litwin, A.
    Phelan, J., III
    Gibbs, J.
    Iyer, R.
    BRITISH JOURNAL OF CANCER, 2009, 100 (12) : 1842 - 1845
  • [30] Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
    M Javle
    J Yu
    C Garrett
    A Pande
    B Kuvshinoff
    A Litwin
    J Phelan
    J Gibbs
    R Iyer
    British Journal of Cancer, 2009, 100 : 1842 - 1845
12345